journal
MENU ▼
Read by QxMD icon Read
search

Prostate International

journal
https://www.readbyqxmd.com/read/28352623/corrigendum-to-modified-urethrovesical-anastomosis-during-robot-assisted-simple-prostatectomy-technique-and-results-prostate-int-4-2016-61-64
#1
Octavio A Castillo, Ivar Vidal-Mora, Arquimedes Rodriguez-Carlin, Andres Silva, Oscar Schatloff, Vincenzo Borgna
[This corrects the article DOI: 10.1016/j.prnil.2016.04.001.].
March 2017: Prostate International
https://www.readbyqxmd.com/read/28352622/predictive-factor-of-androgen-deprivation-therapy-for-patients-with-advanced-stage-prostate-cancer
#2
Chaiyut Kongseang, Worapat Attawettayanon, Watid Kanchanawanichkul, Choosak Pripatnanont
BACKGROUND: The purpose of this study was to identify the predictive factors for the efficacy of androgen deprivation therapy (ADT) in men with hormone-sensitive prostate cancer (PC) with or without distant metastasis. METHODS: A retrospective review of PC patients was conducted of the medical records. We enrolled 246 patients who received primary ADT. PC patients treated with ADT for presumed nonlocalized PC were evaluated on the efficacy of ADT using prostate-specific antigen (PSA) time to progression (TTP) and compared factors associated with TTP in patients with distant metastasis and patients without distant metastasis...
March 2017: Prostate International
https://www.readbyqxmd.com/read/28352621/granulomatous-prostatitis-clinical-and-histomorphologic-survey-of-the-disease-in-a-tertiary-care-hospital
#3
Prakriti Shukla, Hanni V Gulwani, Sukhpreet Kaur
BACKGROUND: Granulomatous prostatitis is an uncommon entity that is diagnosed incidentally on histopathology and is broadly classified as nonspecific, specific, postsurgical (post-transurethral resection), or secondary to other rare systemic granulomatous diseases. Only very few studies are available in the literature that describe the clinical and histomorphological spectrum of the disease. METHODS: A retrospective analysis of histopathological records of 1,181 prostatic specimens received in the pathology department was done over a period of 13 years (January 2003 to January 2016)...
March 2017: Prostate International
https://www.readbyqxmd.com/read/28352620/indications-for-a-second-prostate-biopsy-in-patients-suspected-with-prostate-cancer-after-an-initial-negative-prostate-biopsy
#4
Kwang Suk Lee, Kyo Chul Koo, Kang Su Cho, Seung Hwan Lee, Woong Kyu Han, Young Deuk Choi, Sung Joon Hong, Sang Un Park, Suk Young Lee, Woo Jin Ko, Young Sig Kim, Byung Ha Chung
BACKGROUND: The present study aimed to evaluate the indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy. METHODS: The present study included 421 patients who underwent repeat prostate biopsy between January 2007 and December 2015 at three hospitals. Clinicopathological data, including patient age, body mass index, history of prostate biopsy, prostate volume, prostate-specific antigen (PSA) level, PSA density, PSA velocity, and PSA fluctuation patterns, were analyzed...
March 2017: Prostate International
https://www.readbyqxmd.com/read/28352619/low-levels-of-serum-testosterone-in-middle-aged-men-impact-pathological-features-of-prostate-cancer
#5
Elton Llukani, Benjamin F Katz, Ilir Agalliu, Andrew Lightfoot, Sue-Jean S Yu, Martin Kathrins, Ziho Lee, Yu-Kai Su, Kelly Monahan Agnew, Alice McGill, Daniel D Eun, David I Lee
BACKGROUND: Serum testosterone deficiency increases with aging. Age is also a major risk factor for prostate cancer (PrCa) and PCa tumors are more frequently diagnosed among men >65 years old. We evaluated the relationship between preoperative serum testosterone and clinical/ pathological features of PrCa in middle-aged and elderly patients. METHODS: A total of 605 PrCa patients who underwent robotic-assisted radical prostatectomy between September 2010 and January 2013 at the University of Pennsylvania, and who had serum testosterone levels measured using Elecsys Testosterone II Immunoassay were included in this IRB-approved protocol...
March 2017: Prostate International
https://www.readbyqxmd.com/read/28352618/safety-and-feasibility-of-robot-assisted-radical-prostatectomy-for-clinically-localized-prostate-cancer-in-elderly-japanese-patients
#6
Masatomo Nishikawa, Hiromitsu Watanabe, Tomofumi Kurahashi
BACKGROUND: This study was conducted to assess the safety and feasibility of robot-assisted radical prostatectomy (RARP) for elderly Japanese (aged ≥ 70 years) patients with clinically localized prostate cancer (PCa). METHODS: From April 2012 to March 2016, a total of 302 consecutive patients with clinically localized PCa underwent RARP at our institute. In this series, 109 (36.1%) and 193 (63.9%) of the patients were divided into older (aged ≥ 70 years) and younger (aged <70 years) groups, respectively...
March 2017: Prostate International
https://www.readbyqxmd.com/read/28352617/support-for-the-use-of-objective-comorbidity-indices-in-the-assessment-of-noncancer-death-risk-in-prostate-cancer-patients
#7
Sweet Ping Ng, Gillian Duchesne, Keen-Hun Tai, Farshad Foroudi, Gargi Kothari, Scott Williams
BACKGROUND: Prostate cancer management involves a balance between the risks of cancer death against those from other causes. To evaluate the performance of several comorbidity indices in predicting comorbid death in a prostate cancer radiotherapy cohort. METHODS: 2,131 men with localised prostate cancer treated with radical radiotherapy between 1999 and 2007 were studied. Tumour features, androgen deprivation usage, age, number of prescription medications (PMN) and Adult Comorbidity Evaluation-27 Index (ACE-27) were recorded...
March 2017: Prostate International
https://www.readbyqxmd.com/read/28352616/management-of-metastatic-castration-resistant-prostate-cancer-insights-from-urology-experts-in-thailand
#8
REVIEW
Bannakij Lojanapiwat, Choosak Pripatnanont, Vorapot Choonhaklai, Surithorn Soontornpun, Supon Sriplakich, Sunai Leewansangtong, Apirak Santi-Ngamkun, Julin Opanuraks, Wisoot Kongcharoensombat, Bhapapak Na-Songkla, Wiroj Raksakul, Chagkrapan Predanon
Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-life experiences about how to identify CRPC; (2) to choose the appropriate treatment for CRPC patients; (3) to evaluate disease progression using novel inhibitors of the androgen receptor pathway; (4) to identify the frequency of monitoring disease; and (5) to promote rational use of corticosteroids in CRPC patients...
March 2017: Prostate International
https://www.readbyqxmd.com/read/27995116/studying-the-effect-of-type-2-diabetes-mellitus-on-prostate-related-parameters-a-prospective-single-institutional-study
#9
Ahmed Elabbady, Mohamed M Hashad, Ahmed F Kotb, Ali E Ghanem
BACKGROUND: To examine the effects of type 2 diabetes mellitus (DM) on the variables associated with prostatic growth including serum prostate-specific antigen (PSA), serum testosterone, and prostate volume, and to correlate these variables with the duration of diabetes treatment. METHODS: Our study was conducted over 3 months recruiting 501 men aged ≥ 55 years; of whom 207 had type 2 DM. Exclusion criteria were active urinary tract infection, suspicious rectal examination, urologic cancer, end-organ damage, and recent urological manipulations...
December 2016: Prostate International
https://www.readbyqxmd.com/read/27995115/impact-of-gleason-pattern-5-on-outcomes-of-patients-with-prostate-cancer-and-iodine-125-prostate-brachytherapy
#10
Tomoyuki Makino, Sotaro Miwa, Kiyoshi Koshida
BACKGROUND: The Gleason grading system is a powerful predictor of prostate cancer (PCa) prognosis. Gleason scores (GS) of 8-10 are considered as a single high-risk grade category, and Gleason Pattern 5 (GP5) predicts biochemical recurrence. We report the clinical outcomes of patients treated with (125)I prostate brachytherapy for clinically localized PCa and prognosis in the presence or absence of GP5. METHODS: We enrolled 316 patients with T1c-T2N0M0 PCa and undergoing prostate brachytherapy treatment...
December 2016: Prostate International
https://www.readbyqxmd.com/read/27995114/gleason-group-concordance-between-biopsy-and-radical-prostatectomy-specimens-a-cohort-study-from-prostate-cancer-outcome-registry-victoria
#11
Sue M Evans, Varuni Patabendi Bandarage, Caroline Kronborg, Arul Earnest, Jeremy Millar, David Clouston
BACKGROUND: A new prostate cancer (PCa) prognostic grading system [Gleason groups (GGs)] has been proposed based on the contemporary Gleason scores (GSs), which has five simplified prognostic categories. The objective of this study was to evaluate the agreement between the GGs of prostate biopsy and radical prostatectomy specimens and to identify predictive factors for upgrading GGs. METHODS: A total of 5339 cases of RP notified to the Prostate Cancer Outcomes Registry, Victoria, Australia over 6 years (2009-2014) from 46 hospitals, were included...
December 2016: Prostate International
https://www.readbyqxmd.com/read/27995113/feasibility-of-classical-secondary-hormonal-therapies-prior-to-docetaxel-therapy-in-japanese-patients-with-castration-resistant-prostate-cancer-multicenter-retrospective-study
#12
Shuya Kandori, Takayuki Yoshino, Masakazu Tsutsumi, Atsushi Yamauchi, Mikinobu Ohtani, Yoshiharu Fukuhara, Naoto Miyanaga, Jun Miyazaki, Hiroyuki Nishiyama, Toru Shimazui
BACKGROUND: We retrospectively analyzed castration-resistant prostate cancer (CRPC) patients treated with secondary hormonal therapies (SHTs) prior to docetaxel therapy. METHODS: The cases of 73 CRPC patients who underwent docetaxel therapy in 2005-2011 at four hospitals in Ibaraki, Japan were analyzed. We determined the cause-specific survival (CSS) from the start of docetaxel therapy and the time point of CRPC diagnosis, and we compared the CSS achieved with/without prior classical SHTs, which were defined as low-dose steroid and estramustine phosphate...
December 2016: Prostate International
https://www.readbyqxmd.com/read/27995112/primary-care-follow-up-of-radical-prostatectomy-patients-a-regional-new-zealand-experience
#13
Omid Yassaie, Ben McLaughlin, Marlon Perera, Todd Manning, Nathan Lawrentschuk, Andrew Malcolm
BACKGROUND: Contemporary recommendations regarding the duration of follow-up after radical prostatectomy (RP) are highly heterogeneous. Protocol-based follow-up schemes have been implemented to facilitate the expeditious identification of patients with recurrence. The aim of this study is to assess the reliability and comfort of general practitioners (GPs) in follow-up of RP. METHODS: Following institutional ethical approval, we performed a retrospective review in patients undergoing follow-up after RP between January 2004 and December 2010...
December 2016: Prostate International
https://www.readbyqxmd.com/read/27995111/prostate-cancer-biomarkers-are-we-hitting-the-mark
#14
REVIEW
Shannon McGrath, Daniel Christidis, Marlon Perera, Sung Kyu Hong, Todd Manning, Ian Vela, Nathan Lawrentschuk
PURPOSE: Localised prostate cancer diagnosis and management is increasingly complex due to its heterogeneous progression and prognostic subgroups. Pitfalls in current screening and diagnosis have prompted the search for accurate and invasive molecular and genetic biomarkers for prostate cancer. Such tools may be able to distinguish clinically significant cancers from less aggressive variants to assist with prostate cancer risk stratification and guide decisions and healthcare algorithms...
December 2016: Prostate International
https://www.readbyqxmd.com/read/27995110/prostate-cancer-screening-with-prostate-specific-antigen-a-guide-to-the-guidelines
#15
REVIEW
Sonja Cabarkapa, Marlon Perera, Shannon McGrath, Nathan Lawrentschuk
BACKGROUND: Prostate cancer remains the most common non-skin cancer malignancy in men. Prostate-specific antigen (PSA) is recognized as a biomarker for the diagnosis, monitoring, and risk prediction of prostate cancer. Its use in the setting of prostate cancer screening has been controversial due to the risk of over diagnosis and over treatment. OBJECTIVE: Within Australia, there are inconsistent recommendations surrounding the use of PSA screening in clinical practice...
December 2016: Prostate International
https://www.readbyqxmd.com/read/27689070/incidence-and-mortality-of-prostate-cancer-and-their-relationship-with-the-human-development-index-worldwide
#16
S Hassanipour-Azgomi, Abdollah Mohammadian-Hafshejani, Mahshid Ghoncheh, Farhad Towhidi, Saeid Jamehshorani, Hamid Salehiniya
BACKGROUND: The aim of this study was to evaluate the incidence and mortality of prostate cancer and their relationship with the Human Development Index (HDI) and its components in Asia in 2012. METHODS: This study was an ecological study conducted based on the GLOBOCAN project of the World Health Organization. The correlation between standardized incidence rate (SIR) and standardized mortality rate (SMR) of prostate cancer with HDI and its components was assessed using SPSS Inc Version 18...
September 2016: Prostate International
https://www.readbyqxmd.com/read/27689069/optimizing-prophylactic-antibiotic-regimen-in-patients-admitted-for%C3%A2-transrectal-ultrasound-guided-prostate-biopsies-a-prospective-randomized-study
#17
Ahmed Fahmy, Hazem Rhashad, Mohamed Mohi, Ahmed Elabbadie, Ahmed Kotb
BACKGROUND: Transrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of the most frequently performed urological office procedures, are associated with a spectrum of complications, most significantly including infection. The aim of the study is to evaluate the prevalence of fluoroquinolone-resistant bacteria in rectal swabs from our local population prior to TRUSBx and to identify risk factors among a patient population harboring fluoroquinolone-resistant organisms...
September 2016: Prostate International
https://www.readbyqxmd.com/read/27689068/incidental-prostate-cancer-diagnosed-at-radical-cystoprostatectomy-for-bladder-cancer-disease-specific-outcomes-and-survival
#18
Joshua B Kaelberer, Michael A O'Donnell, Darrion L Mitchell, Anthony N Snow, Sarah L Mott, John M Buatti, Mark C Smith, John M Watkins
BACKGROUND: The current standard of care for men with muscle-invasive bladder cancer is radical cystoprostatectomy (RCP). One-third of RCP specimens demonstrate incidental prostate cancer, primarily reported in small series with limited follow-up. The aim of this study is to report mature outcomes, including patterns of failure and disease-specific recurrence rates, and survival, for a large cohort of men with incidental prostate cancer at RCP performed at a tertiary referral center. METHODS: This retrospective study describes cancer control and survival rates for men who underwent RCP for bladder cancer and were found incidentally to have prostate cancer...
September 2016: Prostate International
https://www.readbyqxmd.com/read/27689067/cytoreductive-surgery-for-men-with-metastatic-prostate-cancer
#19
Nikolas Katelaris, Declan Murphy, Nathan Lawrentschuk, Athos Katelaris, Daniel Moon
BACKGROUND: Cytoreductive surgery for metastatic prostate cancer is an emerging area of interest with a potential upside that includes local control, delayed initiation of hormone therapy, and possibly improved cancer specific survival. In order for radical prostatectomy to be an effective treatment option for men in this group, the benefits must outweigh the surgical morbidity. The aim of this study was to present a case series and assess the literature feasibility of cytoreductive surgery for men with metastatic prostate cancer...
September 2016: Prostate International
https://www.readbyqxmd.com/read/27689066/prostate-based-biofluids-for-the-detection-of-prostate-cancer-a-comparative-study-of-the-diagnostic-performance-of-cell-sourced-rna-biomarkers
#20
Matthew J Roberts, Renee S Richards, Clement W K Chow, Suhail A R Doi, Horst Joachim Schirra, Marion Buck, Hemamali Samaratunga, Joanna Perry-Keene, Diane Payton, John Yaxley, Martin F Lavin, Robert A Gardiner
BACKGROUND: Prostate cancer (PCa) diagnosis requires improvement with the aid of more accurate biomarkers. Postejaculate urethral washings (PEUW) could be a physiological equivalent to urine obtained following rectal prostatic massage, the current basis for the prostate cancer antigen 3 (PCA3) test. The aim of this study was to investigate if PEUW contained prostate-based material, evidenced by the presence of prostate specific antigen (PSA), and to evaluate the diagnostic performance of PEUW-based biomarkers...
September 2016: Prostate International
journal
journal
47870
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"